These changes were associated with an increase in expression of pro-apoptotic genes such as BAD, BAX, BID, and FAS, and downregulation of anti-apoptotic CCND1 and CDK2 in AGS gastric cancer cells (Figure 4). This evidence concerns the gene BID and gastric cancer.